title: Poly(trehalose): sugar-coated nanocomplexes promote stabilization and effective polyplex-mediated siRNA delivery.
abstract: When nanoparticles interact with their environment, the nature of that interaction is governed largely by the properties of its outermost surface layer. Here, we exploit the exceptional properties of a common disaccharide, trehalose, which is well-known for its unique biological stabilization effects. To this end, we have developed a synthetic procedure that readily affords a polymer of this disaccharide, poly(methacrylamidotrehalose) or "poly(trehalose)" and diblock copolycations containing this polymer with 51 repeat units chain extended with aminoethylmethacrylamide (AEMA) at three degrees of polymerization (n = 34, 65, and 84). Two series of experiments were conducted to study these diblock copolymers in detail and to compare their properties to two control polymers [PEG-P(AEMA) and P(AEMA)]. First, we demonstrate that the poly(trehalose) coating ensures colloidal stability of polyplexes containing siRNA in the presence of high salt concentrations and serum proteins. Poly(trehalose) retains the ability of trehalose to lower the phase transition energy associated with water freezing and can protect siRNA polyplexes during freeze-drying, allowing complete nanoparticle resuspension without loss of biological function. Second, we show that siRNA polyplexes coated with poly(trehalose) have exceptional cellular internalization into glioblastoma cells that proceeds with zero-order kinetics. Moreover, the amount of siRNA delivered by poly(trehalose) block copolycations can be controlled by the siRNA concentration in cell culture media. Using confocal microscopy we show that trehalose-coated polyplexes undergo active trafficking in cytoplasm upon internalization and significant siRNA-induced target gene down-regulation was achieved with an IC50 of 19 nM. These findings coupled with a negligible cytotoxicity suggests that poly(trehalose) has the potential to serve as an important component of therapeutic nanoparticle formulations of nucleic acids and has great promise to be extended as a new coating for other nanobased technologies and macromolecules, in particular, those related to nanomedicine applications.
authors.affiliation: Department of Chemistry and Macromolecules and Interfaces Institute, Virginia Tech , Blacksburg, Virginia 24060, United States.
authors.forename: Antons
authors.initials: A
authors.lastname: Sizovs
authors.forename: Lian
authors.initials: L
authors.lastname: Xue
authors.forename: Zachary P
authors.initials: ZP
authors.lastname: Tolstyka
authors.forename: Nilesh P
authors.initials: NP
authors.lastname: Ingle
authors.forename: Yaoying
authors.initials: Y
authors.lastname: Wu
authors.forename: Mallory
authors.initials: M
authors.lastname: Cortez
authors.forename: Theresa M
authors.initials: TM
authors.lastname: Reineke
mesh_terms: D001798:Blood Proteins / Q000737:chemistry; D002236:Carbohydrate Conformation; D045744:Cell Line, Tumor; D002470:Cell Survival; D005909:Glioblastoma / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007700:Kinetics; D049329:Nanostructures / Q000737:chemistry*; D011108:Polymers / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism*; D012492:Salts / Q000737:chemistry; D014199:Trehalose / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism*
chemical_list: D001798:Blood Proteins; D011108:Polymers; D034741:RNA, Small Interfering; D012492:Salts; D014199:Trehalose